Sakar Healthcare Q2 Net Profit Rises To ₹11.30 Crore; Revenue Jumps 51.9 Per Cent
New Delhi, October 23, 2026: Sakar Healthcare on Friday reported a consolidated net profit of Rs 11.30 crore for the September quarter, up from Rs 4.54 crore in the year-ago period. Its revenue from operations rose 51.9 per cent to Rs 87.41 crore during the quarter, compared with Rs 57.56 crore a year earlier, according to a regulatory filing. Oncology Business Drives Growth The company said…
Sakar Healthcare announced a significant rise in its net profit for the second quarter of the year, reaching ₹11.30 crore compared to ₹4.54 crore in the same period last year. This growth in profit was accompanied by a substantial increase in revenue, which climbed by 51.9 percent to Rs 87.41 crore, up from Rs 57.56 crore during the previous year's equivalent quarter, as reported in a regulatory filing.
The company attributed this strong performance to several key factors. The oncology business played a crucial role in the growth, driven by recent approvals in this sector, robust demand across different regions, a more favorable mix of oncology-related products or services, improved operating efficiency, and effective cost management practices.
Sanjay Shah, the Managing Director of Sakar Healthcare, highlighted the significance of the quarter, stating, "Q2 has been a quarter of meaningful progress for our oncology business, with encouraging developments across regulatory approvals, technology transfers, and global market access."
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
